Pharmaceutical Preparations · DE · CIK 2096997
Develops diversified GLP-1 based obesity treatments with four clinical-stage candidates
Comparable business profile · signals at a glance
Coverage (30d): 1 reputable article · skews ▲ positive.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗